BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX-V: BCT) is a clinical-stage biotechnology company specializing in targeted immunotherapies for cancer.

Biotechnology

BriaCell Therapeutics

BriaCell Therapeutics' headquarters in New York, NY, United States

William V. Williams

Miguel A. Lopez-Lago

Marc Lustig

Thomas Kieber-Emmons

Doug Faller

Charles L. Wiseman

Brian Metcalf

Cara L. Haymaker

Jane A. Gross

Jamieson Bondarenko

Martin E. Schmieg

Rebecca Taub

Alexander Kharazi

Vaughn C. Embro-Pantalony

The Research and Development Team at BriaCell Therapeutics is responsible for designing and conducting innovative preclinical and clinical studies to advance the company's targeted immunotherapy treatments for cancer. This team collaborates closely with various scientific advisors and specialists to optimize research strategies, analyze data, and ensure effective translation of laboratory findings into clinical applications, ultimately contributing to the development of groundbreaking therapies in the fight against cancer.

Research and Development Team

BriaCell Therapeutics

Org chart

Board & advisors

Teams

Research and Development Team

Offices

BriaCell Therapeutics

Org chart

Board & advisors

Teams

Research and Development Team

Offices

Related companies